Qinheli Biomedical
Shanghai
About Qinheli Biomedical
Qinheli Biomedical is a tumor micro-environment-responsive drug developer dedicated to the development and production of low-toxic and highly effective patented anti-cancer drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $8.7M
- Funding stage: Private Equity
- Last round: Private Equity (Apr 2021)
- Website: affinity.net.cn
Industries & Categories
Health Care, Medical
Canonical: https://fsome.com/organization/qinheli-biomedical-118486 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.